Answers are grounded in this paper and cite their sources.
Finds that baseline visual acuity affects outcomes with aflibercept in diabetic macular edema, suggesting treatment effectiveness regardless of baseline vision levels.
Aflibercept 8 mg demonstrated comparable visual and anatomic improvements versus 2 mg in patients with diabetic macular edema at week 96, regardless of baseline best-corrected visual acuity ≤20/50 versus ≥20/40.
No takes yet. Share an insight, caveat, or question.
Javaheri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: